Truist Financial Corp Trims Stock Position in Globe Life Inc. $GL

Truist Financial Corp reduced its stake in Globe Life Inc. (NYSE:GL) by 29.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 28,341 shares of the company’s stock after selling 11,657 shares during the quarter. Truist Financial Corp’s holdings in Globe Life were worth $4,052,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of GL. Synergy Asset Management LLC lifted its holdings in Globe Life by 1,022.7% in the third quarter. Synergy Asset Management LLC now owns 100,603 shares of the company’s stock valued at $14,240,000 after acquiring an additional 91,642 shares during the period. SteelPeak Wealth LLC purchased a new position in shares of Globe Life in the 3rd quarter valued at about $2,985,000. Inspire Investing LLC purchased a new position in shares of Globe Life in the 3rd quarter valued at about $1,062,000. MGO One Seven LLC acquired a new stake in shares of Globe Life in the third quarter valued at about $1,364,000. Finally, Retirement Systems of Alabama purchased a new stake in Globe Life during the third quarter worth about $2,470,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Price Performance

GL stock opened at $144.79 on Thursday. Globe Life Inc. has a 1 year low of $109.38 and a 1 year high of $147.83. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07. The stock’s 50 day moving average price is $138.89 and its 200 day moving average price is $137.73. The firm has a market cap of $11.53 billion, a P/E ratio of 10.49 and a beta of 0.47.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.81% and a net margin of 19.36%.The company had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the business posted $3.14 EPS. The business’s quarterly revenue was up 3.6% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have issued reports on GL. TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Truist Financial upped their price target on Globe Life from $150.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, October 24th. Piper Sandler reaffirmed an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a research note on Friday, November 21st. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a report on Tuesday, October 28th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Globe Life has a consensus rating of “Moderate Buy” and an average price target of $166.22.

Key Globe Life News

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Quarterly operating results improved year-over-year — net operating income was $3.39 per diluted share (up from $3.14 a year ago) and net income rose to $3.29 vs. $3.01 — showing underlying business strength. Read More.
• Positive Sentiment: Profitability metrics remain strong (net margin ~19.4% and ROE ~21.8%), supporting free cash flow/return potential for shareholders. Read More.
• Neutral Sentiment: Management set FY‑2026 EPS guidance at $14.95–$15.65, which is close to analyst consensus (roughly $15.03) — guidance is largely in line but leaves limited upside versus expectations. Read More.
• Neutral Sentiment: Local and college-sports placements of the Globe Life name (games moved to Globe Life Field; articles about teams using the stadium) provide brand exposure but are unlikely to materially affect near-term financials. Read More. Read More.
• Negative Sentiment: Reported EPS of $3.39 missed the consensus by $0.05, and revenue of $1.52B was about $10M below estimates — the modest misses are the main driver of short‑term downside risk. Read More.
• Negative Sentiment: Coverage noted sales below analyst estimates, which could temper analyst revisions or near‑term sentiment if revenue growth concerns persist. Read More.

Insider Buying and Selling

In related news, CEO Frank M. Svoboda sold 9,379 shares of the business’s stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the completion of the transaction, the chief executive officer owned 35,868 shares of the company’s stock, valued at approximately $5,036,943.24. The trade was a 20.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.51% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.